Longview Innovation Corp. 13D and 13G filings for Carisma Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-02 1:06 pm Sale | 2023-12-31 | 13G | Carisma Therapeutics, Inc. CARM | Longview Innovation Corp. | 2,713,232 6.700% | -182,033 (-6.29%) | Filing |
| 2023-03-16 4:08 pm Purchase | 2023-03-07 | 13G | Carisma Therapeutics, Inc. CARM | Longview Innovation Corp. | 2,895,265 7.200% | 2,895,265 (New Position) | Filing |